ESE Stock Analysis: ESCO Technologies | NYSE
Scientific & Technical Instruments | NYSE, USA | Market Cap: 6.013m USD | 12M Return: 8.5% | US2963151046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 67.0M
EPS Trend: 98.1%
Qual. Beats: 0
Rev. Trend: 93.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ESCO Technologies Inc. (NYSE: ESE) is a Saint Louis-based engineered products company operating through three reportable segments: Aerospace & Defense (specialty filtration, electro-explosive devices, precision-machined aerospace components, naval signature-reduction solutions, and power management products); Utility Solutions Group (diagnostic testing solutions and decision-support tools for renewable energy, primarily wind and solar); and RF Test & Measurement (RF energy measurement and control systems, shielded enclosures, RF absorptive materials, filters, antennas, and calibration services for research, regulatory compliance, medical, and security applications). The company was incorporated in 1990.
The business operates as a diversified industrial manufacturer within the GICS Industrials sector (Industrial Machinery & Supplies & Components sub-industry), serving a mix of commercial aerospace, U.S. Department of Defense, naval, and industrial customers across multiple end markets. ESCO reaches its customers through a multi-channel distribution model that combines distributors, independent sales representatives, direct sales teams, and in-house sales personnel, which is typical for niche industrial component suppliers selling into highly regulated and specification-driven markets.
- Navy signature reduction backlog grows amid naval modernization spending
- Aerospace & Defense margins expand on specialty filtration pricing power
- Utility Solutions renewable diagnostic tools gain wind and solar market share
- RF Test & Measurement secured facilities revenue accelerates defense electronics demand
| Net Income: 314.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.10 > 1.0 |
| NWC/Revenue: 16.18% < 20% (prev 23.99%; Δ -7.81% < -1%) |
| CFO/TA 0.10 > 3% & CFO 244.0m > Net Income 314.8m |
| Net Debt (100.0m) to EBITDA (305.7m): 0.33 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.0m) vs 12m ago 0.24% < -2% |
| Gross Margin: 42.01% > 18% (prev 41.05%; Δ 0.95% > 0.5%) |
| Asset Turnover: 52.19% > 50% (prev 42.55%; Δ 9.64% > 0%) |
| Interest Coverage Ratio: 10.41 > 6 (EBIT TTM 199.0m / Interest Expense TTM 19.1m) |
| A: 0.09 (Total Current Assets 755.5m - Total Current Liabilities 546.7m) / Total Assets 2.42b |
| B: 0.60 (Retained Earnings 1.46b / Total Assets 2.42b) |
| C: 0.08 (EBIT TTM 199.0m / Avg Total Assets 2.47b) |
| D: 2.01 (Book Value of Equity 1.62b / Total Liabilities 802.7m) |
| Altman-Z'' = 5.19 = AAA |
| DSRI: 0.68 (Receivables 267.5m/329.7m, Revenue 1.29b/1.07b) |
| GMI: 0.98 (GM 41.05% / 42.01%) |
| AQI: 0.97 (AQ_t 0.60 / AQ_t-1 0.62) |
| SGI: 1.20 (Revenue 1.29b / 1.07b) |
| TATA: 0.03 (NI 314.8m - CFO 244.0m) / TA 2.42b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of October 29, 2026, the stock is trading at USD 240.00 with a total of 181,034 shares traded. Over the past week, the price has changed by -3.04%, over one month by -9.76%, over three months by -23.95% and over the past year by +8.46%.
Current recommended Stop Loss: 229.20 (which is 4.5% or 1.4 ATR below the current price).
ESCO Technologies has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ESE.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 352.8 | 47% |
P/E Trailing = 43.0612
P/E Forward = 25.3807
P/S = 4.6588
P/B = 4.1673
P/EG = 1.6685
Revenue TTM = 1.29b USD
EBIT TTM = 199.0m USD
EBITDA TTM = 305.7m USD
Long Term Debt = 65.0m USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 173.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 44.1m
Net Debt = 100.0m USD (calculated: Debt 173.2m - CCE 73.2m)
Enterprise Value = 6.11b USD (6.01b + Debt 173.2m - CCE 73.2m)
Interest Coverage Ratio = 10.41 (Ebit TTM 199.0m / Interest Expense TTM 19.1m)
EV/FCF = 31.09x (Enterprise Value 6.11b / FCF TTM 196.6m)
FCF Yield = 3.22% (FCF TTM 196.6m / Enterprise Value 6.11b)
FCF Margin = 15.23% (FCF TTM 196.6m / Revenue TTM 1.29b)
Net Margin = 24.39% (Net Income TTM 314.8m / Revenue TTM 1.29b)
Gross Margin = 42.01% ((Revenue TTM 1.29b - Cost of Revenue TTM 748.5m) / Revenue TTM)
Gross Margin QoQ = 41.74% (prev 42.45%)
Tobins Q-Ratio = 2.53 (Enterprise Value 6.11b / Total Assets 2.42b)
Interest Expense / Debt = 11.04% (Interest Expense 19.1m / Debt 173.2m)
Taxrate = 22.25% (40.0m / 179.9m)
NOPAT = 154.7m (EBIT 199.0m * (1 - 22.25%))
Current Ratio = 1.38 (Total Current Assets 755.5m / Total Current Liabilities 546.7m)
Debt / Equity = 0.11 (Debt 173.2m / totalStockholderEquity, last quarter 1.62b)
Debt / EBITDA = 0.33 (Net Debt 100.0m / EBITDA 305.7m)
Debt / FCF = 0.51 (Net Debt 100.0m / FCF TTM 196.6m)
Total Stockholder Equity = 1.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.73% (Net Income 314.8m / Total Assets 2.42b)
RoE = 19.97% (Net Income TTM 314.8m / Total Stockholder Equity 1.58b)
RoCE = 12.13% (EBIT 199.0m / Capital Employed (Equity 1.58b + L.T.Debt 65.0m))
RoIC = 8.46% (NOPAT 154.7m / Invested Capital 1.83b)
WACC = 8.73% (E(6.01b)/V(6.19b) * Re(8.73%) + D(173.2m)/V(6.19b) * Rd(11.04%) * (1-Tc(0.22)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.90 | Cagr: 0.23%
[DCF] Terminal Value 76.76% ; FCFF base≈178.8m ; Y1≈205.0m ; Y5≈301.7m
[DCF] Fair Price = 160.5 (EV 4.26b - Net Debt 100.0m = Equity 4.16b / Shares 25.9m; r=8.73% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.07 | EPS CAGR: 36.21% | SUE: 0.53 | # QB: 0
Revenue Correlation: 93.49 | Revenue CAGR: 11.74% | SUE: -0.05 | # QB: 0
EPS current Quarter (2026-12-31): EPS=1.79 | Chg30d=-1.39% | Revisions=+25% | Analysts=3
EPS current Year (2026-09-30): EPS=8.37 | Chg30d=+0.11% | Revisions=+50% | GrowthEPS=+38.7% | GrowthRev=+19.9%
EPS next Year (2027-09-30): EPS=9.22 | Chg30d=-0.03% | Revisions=+57% | GrowthEPS=+10.2% | GrowthRev=+30.7%
[Analyst] Revisions Ratio: +73% (up=8, down=0)